Skip to main content

Optical and Scanning Electron Microscopy Thrombus Findings in Patients with STEMI Undergoing Primary Versus Rescue PCI.

Publication ,  Journal Article
Pedrini, SM; Aloia, TPA; Aguillera, AH; Gomes, PMPS; Cade, JR; Menezes-Rodrigues, FS; Freitas, BP; Souza, MT; Fonseca, FAH; Oliveira, MD ...
Published in: Biomedicines
September 11, 2025

Background: The mechanisms underlying fibrinolysis failure in patients with STEMI who are undergoing a pharmacoinvasive strategy appear to be multifactorial and may be associated with the thrombus's architecture and composition. Objective: We aimed to compare the thrombus composition in patients with STEMI who were undergoing rescue percutaneous coronary intervention (rPCI) versus primary PCI (pPCI) using optical microscopy (OM) and scanning electron microscopy (SEM). Methods: Fifty-three patients were prospectively enrolled, with twenty-five undergoing rPCI and twenty-eight undergoing pPCI. After thrombus aspiration, each harvested fragment was divided into two pieces: one was analyzed using OM with a 60× magnifying lens on hematoxylin-eosin-stained samples, and the other with SEM at 5000× magnification. Results: Patients who underwent rPCI had significantly higher C-reactive protein levels and a longer ischemic interval at admission compared to those treated with pPCI (9.92 h [range: 1.58-106.17] vs. 2.14 h [range: 0-48]; p < 0.001). Optical microscopy analysis revealed that thrombi from rPCI patients exhibited a significantly higher erythrocyte area percentage (18.36% [range: 0.3-50.08] vs. 0.91% [range: 0-70.1]; p = 0.001), a lower fibrin content as assessed by optical microscopy (79.49% [range: 49.2-98.25] vs. 94.43% [range: 29.19-99.92]; p = 0.006), and a greater amount of cholesterol crystals as measured by SEM (1.73 μm2 [range: 0-18.51] vs. 0.08 μm2 [range: 0-0.71]; p < 0.001). Conclusions: The thrombus composition of patients with STEMI who are undergoing rPCI had higher amounts of erythrocytes and cholesterol crystals and a lesser area occupied by fibrin compared to those undergoing pPCI. The composition of thrombi in rPCI could potentially contribute to the failure of fibrinolytic therapy within a pharmacoinvasive strategy.

Duke Scholars

Published In

Biomedicines

DOI

ISSN

2227-9059

Publication Date

September 11, 2025

Volume

13

Issue

9

Location

Switzerland

Related Subject Headings

  • 3404 Medicinal and biomolecular chemistry
  • 3214 Pharmacology and pharmaceutical sciences
  • 3101 Biochemistry and cell biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pedrini, S. M., Aloia, T. P. A., Aguillera, A. H., Gomes, P. M. P. S., Cade, J. R., Menezes-Rodrigues, F. S., … Caixeta, A. (2025). Optical and Scanning Electron Microscopy Thrombus Findings in Patients with STEMI Undergoing Primary Versus Rescue PCI. Biomedicines, 13(9). https://doi.org/10.3390/biomedicines13092235
Pedrini, Stella Marinelli, Thiago P. A. Aloia, André H. Aguillera, Paula M. P. S. Gomes, Jamil R. Cade, Francisco Sandro Menezes-Rodrigues, Bárbara P. Freitas, et al. “Optical and Scanning Electron Microscopy Thrombus Findings in Patients with STEMI Undergoing Primary Versus Rescue PCI.Biomedicines 13, no. 9 (September 11, 2025). https://doi.org/10.3390/biomedicines13092235.
Pedrini SM, Aloia TPA, Aguillera AH, Gomes PMPS, Cade JR, Menezes-Rodrigues FS, et al. Optical and Scanning Electron Microscopy Thrombus Findings in Patients with STEMI Undergoing Primary Versus Rescue PCI. Biomedicines. 2025 Sep 11;13(9).
Pedrini, Stella Marinelli, et al. “Optical and Scanning Electron Microscopy Thrombus Findings in Patients with STEMI Undergoing Primary Versus Rescue PCI.Biomedicines, vol. 13, no. 9, Sept. 2025. Pubmed, doi:10.3390/biomedicines13092235.
Pedrini SM, Aloia TPA, Aguillera AH, Gomes PMPS, Cade JR, Menezes-Rodrigues FS, Freitas BP, Souza MT, Fonseca FAH, Oliveira MD, Almeida BO, Serra AJ, Lopes RD, Sinigaglia-Coimbra R, Caixeta A. Optical and Scanning Electron Microscopy Thrombus Findings in Patients with STEMI Undergoing Primary Versus Rescue PCI. Biomedicines. 2025 Sep 11;13(9).

Published In

Biomedicines

DOI

ISSN

2227-9059

Publication Date

September 11, 2025

Volume

13

Issue

9

Location

Switzerland

Related Subject Headings

  • 3404 Medicinal and biomolecular chemistry
  • 3214 Pharmacology and pharmaceutical sciences
  • 3101 Biochemistry and cell biology